Annovis Bio, Inc. (FRA:07X)
Germany · Delayed Price · Currency is EUR 2.340
-0.020 (-0.85%)
At close: Jan 30, 2026
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of €60.23 million as of January 30, 2026. Its market cap has decreased by -6.81% in one year.
Market Cap
60.23M
Enterprise Value
47.36M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.34
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has increased from 56.82M to 60.23M, an increase of 6.00%. That is a compound annual growth rate of 0.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 60.23M | -22.88% |
| Dec 31, 2025 | 78.10M | 16.51% |
| Dec 31, 2024 | 67.03M | -61.39% |
| Dec 29, 2023 | 173.62M | 69.23% |
| Dec 30, 2022 | 102.59M | -18.07% |
| Dec 31, 2021 | 125.22M | 194.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CGRE AG | 75.00M |
| Path2 Hydrogen AG | 73.04M |
| InnoTec TSS AG | 68.90M |
| audius SE | 62.99M |
| learnd SE | 60.39M |
| WASGAU Produktions & Handels AG | 59.40M |
| Schwälbchen Molkerei Jakob Berz AG | 58.16M |
| Nordwest Handel AG | 58.01M |